Diabetes Medication Choice

Mayo Clinic

Status: Completed

Conditions: Type 2 Diabetes

Treatments: Behavioral: Diabetes Medication Choice decision aid; Behavioral: Usual Care

Study type: Interventional

Funder types: Other

Identifiers

NCT00388050

ADA #33

06-003513

Details and patient eligibility

About

The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

Enrollment: 85 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not required
• Use 1 or 2 oral hypoglycemic agents; not using insulin therapy
• Are not pregnant
• Have stable but inadequate glycemic control: both A1C at the time of eligibility and previous A1c within 6 months between 7-9.5%
• Recognize their primary care provider as their main diabetes care provider
• Do not have major barriers (i.e., severe hearing impairment, dementia, cannot communicate in English) to participate in shared decision-making (per provider?s assessment)
• Have no plans to relocate out of town in the next 6 months
• Enrolment is open to males and females of diverse racial backgrounds

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

85 participants in 2 patient groups

Diabetes Medication Choice decision aid

Experimental group

Description:

Patients in this arm will discuss diabetes medication for glucose control with the help of a decision aid that covers five commonly prescribed anti-hyperglycemic medications.

Treatment:

Behavioral: Diabetes Medication Choice decision aid

Usual Care

Other group

Description:

Patients and clinicians in this arm will discuss anti-hyperglycemic agents in their usual manner.

Treatment:

Behavioral: Usual Care